Bracco Diagnostics #00270131525 Isovue®-300 Iopamidol 61% Injection Vial 30 mL ISOVUE-300, VL 61% 30ML (10/CS) Features Isovue* (iopamidol injection) is a safe and effective nonionic contrast medium Manufacturer # 00270131525 Brand Isovue®-300 Manufacturer Bracco Diagnostics Country of Origin Italy Application Contrast Media Container Type Vial Dosage Form Injection Generic Drug Code 10870 Generic Drug Name Iopamidol NDC Number 00270131525 Strength 61% UNSPSC Code 51442423 Volume 30 mL Bracco Diagnostics #00270-1315-30 ISOVUE®-300* (Iopamidol Injection 61%) Ten 50 mL bottles ISOVUE® (Iopamidol Injection) is approved for computed tomography (CT) in adults and children, and is available in a wide selection of concentrations and fill sizes used by today's health care professionals. Multiple studies worldwide confirm its tolerability, safety and efficacy. ISOVUE® (Iopamidol Injection) ISOVUE-200 (Iopamidol Injection 41%)ISOVUE-250 (Iopamidol Injection 51%)ISOVUE-300 (Iopamidol Injection 61%)ISOVUE-370 (Iopamidol injection 76%) The ISOVUE product line represents our dedication to the research, development, and production of quality contrast media as well as our focus on improving diagnostic imaging efficacy, cost-effectiveness, and—most importantly—patient safety. Looking to improve efficiency in your department, while potentially reducing cost? Ask your Bracco representative about the benefits of using ISOVUE (Iopamidol Injection) Imaging Bulk Package (IBP) in combination with the Bracco Injeneering transfer set and EmpowerCTA®+ Injector System, or for the ultimate in efficiency and workflow, utilizing ISOVUE IBP and the CT Exprès® 3D Contrast Media Delivery System. ISOVUE for Computed Tomography ISOVUE contrast media for computed tomography (CT) helps create clear, distinct images, resulting in more efficient procedures. Technologists have a variety of options to choose from to ensure the best possible images for every patient. ISOVUE IBP was the first contrast medium approved in an Imaging Bulk Package by the U.S. Food and Drug Administration for point of care, multi-dose, multi-patient use without the need for a "suitable work area". This allows for compliant patient-centric contrast media dosing, which minimizes waste and associated cost.
Size: 300MG 50ML
More Information
